Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2005;46:1368-1373
Published online before print October 24, 2005, doi: 10.1161/01.HYP.0000188905.20884.63
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
46/6/1368    most recent
01.HYP.0000188905.20884.63v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, Z.
Right arrow Articles by Deddish, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, Z.
Right arrow Articles by Deddish, P. A.
Related Collections
Right arrow ACE/Angiotension receptors
Right arrow Other Research

(Hypertension. 2005;46:1368.)
© 2005 American Heart Association, Inc.


Original Articles

Hydrolysis of Angiotensin Peptides by Human Angiotensin I–Converting Enzyme and the Resensitization of B2 Kinin Receptors

Zhenlong Chen; Fulong Tan; Ervin G. Erdös; Peter A. Deddish

From the Departments of Pharmacology (Z.C., F.T., E.G.E., P.A.D.), Anesthesiology (F.T., E.G.E.), and Anatomy and Cell Biology (P.A.D.), University of Illinois College of Medicine, Chicago.

Correspondence to Ervin G. Erdös, MD, Professor, Department of Pharmacology, 835 S Wolcott (MC 868), Chicago, IL 60612. E-mail EGErdos{at}uic.edu

We measured the cleavage of angiotensin I (Ang I) metabolites by angiotensin I–converting enzyme (ACE) in cultured cells and examined how they augment actions of bradykinin B2 receptor agonists. Monolayers of Chinese hamster ovary cells transfected to stably express human ACE and bradykinin B2 receptors coupled to green fluorescent protein (B2GFP) or to express only coupled B2GFP receptors. We used 2 ACE-resistant bradykinin analogues to activate the B2 receptors. We used high-performance liquid chromatography to analyze the peptides cleaved by ACE on cell monolayers and found that Ang 1-9 was hydrolyzed 18x slower than Ang I and &30% slower than Ang 1-7. Ang 1-7 was cleaved to Ang 1-5. Although µmol/L concentrations of slowly cleaved substrates Ang 1-7 and Ang 1-9 inhibit ACE, they resensitize the desensitized B2GFP receptors in nmol/L concentration, independent of ACE inhibition. This is reflected by release of arachidonic acid through a mechanism involving cross-talk between ACE and B2 receptors. When ACE was not expressed, the Ang 1-9, Ang 1-7 peptides were inactive. Inhibitors of protein kinase C-{alpha}, phosphatases and Tyr-kinase blocked this resensitization activity, but not basal B2 activation by bradykinin. Ang 1-9 and Ang 1-7 enhance bradykinin activity, probably by acting as endogenous allosteric modifiers of the ACE and B2 receptor complex. Consequently, when ACE inhibitors block conversion of Ang I, other enzymes can still release Ang I metabolites to enhance the efficacy of ACE inhibitors.


Key Words: angiotensin • angiotensin-converting enzyme • bradykinin • enalapril • protein kinases




This article has been cited by other articles:


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
G. J Dietze and E. J Henriksen
Review: Angiotensin-converting enzyme in skeletal muscle: sentinel of blood pressure control and glucose homeostasis
Journal of Renin-Angiotensin-Aldosterone System, June 1, 2008; 9(2): 75 - 88.
[Abstract] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
J. C. Q. Velez, A. M. Bland, J. M. Arthur, J. R. Raymond, and M. G. Janech
Characterization of renin-angiotensin system enzyme activities in cultured mouse podocytes
Am J Physiol Renal Physiol, July 1, 2007; 293(1): F398 - F407.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
Z. Chen, P. A. Deddish, R. D. Minshall, R. P. Becker, E. G. Erdos, and F. Tan
Human ACE and bradykinin B2 receptors form a complex at the plasma membrane
FASEB J, November 1, 2006; 20(13): 2261 - 2270.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
E. G. Erdos
The ACE and I: how ACE inhibitors came to be
FASEB J, June 1, 2006; 20(8): 1034 - 1038.
[Full Text] [PDF]


Home page
Circ. Res.Home page
I. Fleming
Signaling by the Angiotensin-Converting Enzyme
Circ. Res., April 14, 2006; 98(7): 887 - 896.
[Abstract] [Full Text] [PDF]